Breast cancer cells can also acquire resistance to paclitaxel by switching from apoptosis to autophagy, which results in downregulation of the mammalian target of rapamycin (mTOR) pathway along with an increased ability of breast cancer cells to survive under stress conditions [29]. This evidence concerns the gene MTOR and breast cancer.